ReviewEndocrine connections2025
Mutational landscapes of HNF MODY gene products display a wide distribution with functional implications.
Review in Endocrine connections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transcriptional drivers and endocrine disorders.Endocrine connections · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatocyte nuclear factors (HNFs) play an essential role in the development and function of vital organs such as the liver, kidney, intestine, and pancreas by regulating the expression of multiple genes involved in organ development, nutrient transport, and diverse metabolic pathways. Among them, HNF1α, HNF1β, and HNF4α play critical roles in glucose-stimulated insulin secretion in pancreatic β-cells and are monogenic causes of diabetes referred to as maturity-onset diabetes of the young (MODY). Numerous mutations have been identified in MODY patients, and the numbers are growing. MODY mutations disrupt protein structure/function in specific ways, and deciphering the exact molecular mechanisms of their mutational effects is vital for better understanding their molecular function and potential therapeutic intervention. This article compiles the updated overall landscapes of missense mutations in members of these transcription factors. We show that mutations are widely but unevenly distributed in their sequence and molecular structures and infer their functional implications. We map the variants to several hotspot residues. While some mutations have been previously characterized, we find that significant proportions of them remain to be mechanistically defined. Because these proteins represent ideal targets to improve β-cell function and survival, we discuss the status and prospects for therapeutic intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.